1[2]Knosp E,Steiner E,Kitz K,et al.Pituitary adenomas with invasion of the cavernous sinus space:a magnetic resonance imaging classification compared with surgical findings[J].Neurosurgery,1993,33:610～617
2[4]Jaalinoja J,Herva R,Korpela M,et al.Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms[J].Neurooncol,2000,46:81～90
3[5]Beaulieu E,Kachra Z,Mousseau N,et al.Matrix metalloproteinases and their inhibitors in human pituitary tumors[J].Neurosurgery,1999,45:1432～1440
4[6]Turner HE,Nagy Z,Esiri MM,et al.Role of matrix metalloproteinase 9 in pituitary tumor behavior[J].Clin Endocrinol Metab,2000,85:2931～2935
5[7]Kawamoto H,Kawamoto K,Mizoue T,et al.Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis[J].Acta Neurochir (Wien),1996,138:1442～1448
6[8]Paez Pereda M,Ledda MF,Goldberg V.High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells[J].Clin Endocrinol Metab,2000,85:263～269
7[9]Vu TH,Shipley JM,Bergers G,et al.MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes[J].Cell,1998,93:411～422
